Study to Validate the Application of the Epidemiological Diagnostic Criteria of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified to the Brazilian Health Regulatory Agency (ANVISA)
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Giovanna Marssola Nascimento
- Enrollment
- 987
- Locations
- 12
- Primary Endpoint
- Incidence of Ventilator-Associated Pneumonia (VAP) using two different surveillance criteria.
Overview
Brief Summary
Multicentric observational prospective cohort study in 12 (twelve) hospitals representing all Brazilian regions.
The main objective of this project is to evaluate the incidence of Ventilator-Associated Pneumonia (VAP) when using the current ANVISA criteria for VAP versus VAE criteria defined by the National Healthcare Safety Network (NHSN). The diagnostic accuracy of the two criteria for identifying VAP will also be compared, characterizing other events associated with mechanical ventilation that are not VAP, when applicable.
The study also aims to adjudicate ventilator-associated pneumonias reported to ANVISA using current epidemiological diagnostic criteria.
Detailed Description
The study will be carried out in about 12 centers, comprising the five Brazilian regions. It will be conducted from 2022 to 2024. Data collection will be performed at each center during six months.
Trained health professionals from Infections Control Committees of each participating center will collect data.
Mechanical ventilation data will be entered daily in the database system from the moment the patient is submitted to mechanical ventilation until the first day after the end of mechanical ventilation.
VAPs notified to ANVISA, according to its own criteria, will be reported monthly in the database system for adjudication.
The VAE definition will be performed automatically in the database system by mans of a specific algorithm. The diagnosis established by the system will be manually validated by a nurse with experience in healthcare-associated infection (HAI) surveillance. Agreement variables (Kappa) between the two criteria will be analyzed.
The adjudication will be carried out by two independent professionals (doctor and nurse) with experience in HAIs surveillance. In case of disagreement, there will be an evaluation by a third adjudicator.
The complete project was submitted to the local Institutional Review Board (IRB)/National Research Ethics Commission (CONEP) system and has ethical approval (CAAE: 52354721.0.1001.0070).
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients aged 18 years or older
- •Pacients hospitalized in intensive care units (ICUs) using mechanical ventilation
Exclusion Criteria
- •Patients withdrawn from mechanical ventilation (MV) on the first day (D1) or second day (D2), with D1 being the day of initiation of MV;
- •Patients with hospital discharge (discharge, death or transfer) on D1 or D2 of mechanical ventilation
Outcomes
Primary Outcomes
Incidence of Ventilator-Associated Pneumonia (VAP) using two different surveillance criteria.
Time Frame: through study completion, an average of 6 months
To evaluate the incidence of Ventilator-Associated Pneumonia (VAP) when using the current ANVISA criteria for VAP versus the criteria for events Ventilator-Associated Events (VAE) defined by the NHSN.
Secondary Outcomes
- Accuracy of the two criteria for identifying VAP(through study completion, an average of 6 months)
- Adjudication of VAP(through study completion, an average of 6 months)
Investigators
Giovanna Marssola Nascimento
Principal Investigator
Hospital Alemão Oswaldo Cruz